Metagenomi Inc. Common St... (MGX)
2.86
0.10 (3.62%)
At close: Jan 15, 2025, 9:35 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 |
| Net Income | -68.25M | -43.59M | -21.44M |
| Depreciation & Amortization | 4.21M | 1.73M | 387.00K |
| Stock-Based Compensation | 6.92M | 1.96M | 375.00K |
| Other Working Capital | -23.89M | 65.66M | 44.23M |
| Other Non-Cash Items | -7.85M | 1.08M | 1.24M |
| Deferred Income Tax | n/a | n/a | n/a |
| Change in Working Capital | -26.43M | 69.49M | 46.26M |
| Operating Cash Flow | -91.41M | 29.72M | 24.26M |
| Capital Expenditures | -9.81M | -13.98M | -2.90M |
| Acquisitions | n/a | n/a | n/a |
| Purchase of Investments | -208.10M | -214.85M | -71.41M |
| Sales Maturities Of Investments | 263.64M | 106.63M | n/a |
| Other Investing Acitivies | n/a | -108.22M | -71.41M |
| Investing Cash Flow | 45.73M | -122.20M | -74.32M |
| Debt Repayment | n/a | n/a | 29.97M |
| Common Stock Repurchased | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a |
| Other Financial Acitivies | 1.01M | 239.59M | 9.95M |
| Financial Cash Flow | 1.01M | 239.59M | 39.92M |
| Net Cash Flow | -44.66M | 147.12M | -10.14M |
| Free Cash Flow | -101.22M | 15.75M | 21.35M |